Abiopharma

🔍 Riley Corey Neil (Executive)

Company: Riley Exploration Permian, Inc. (REPX)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 40 shares of Common Stock, par value $0.001 per share at $34.4 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 213,522.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 3,460 shares of Common Stock, par value $0.001 per share at $35.2107 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 210,062.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person, dated July 12, 2025.
• F2: This amount includes 133,791 shares of restricted common stock subject to vesting and certain other restrictions.
• F3: The price reported reflects the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.6850 to $35.6550, inclusive. These open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.